|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection显示文摘AIM: To determine the efficacy of our therapeutic strategy for Helicobacter pylori (H. pylori) eradication and to identify predictive factors for successful eradication. METHODS: From April 2006 to June 2010, we retrospectively assessed 2428 consecutive patients (1025 men, 1403 women; mean age 55 years, age range 18-92 years) with gastric histology positive for H. pylori infection referred to our unit for 13-C urea breath test(UBT), after first-line therapy with proton pump inhibitor (PPI) b.i.d. + amoxicillin 1 g b.i.d. + clarithromycin 500 mg b.i.d. for 7 d. Patients who were still positive to UBT were recommended a second-line therapy (PPI b.i.d. + amoxicillin 1 g b.i.d. + tinidazole 500 mg b.i.d. for 14 d). Third choice treatment was empirical with PPI b.i.d. + amoxicillin 1 g b.i.d. + levofloxacin 250 mg b.i.d. for 14 d. RESULTS: Out of 614 patients, still H. pylori-positive after first-line therapy, only 326 and 19 patients respectively rechecked their H. pylori status by UBT after the suggested second and third-line regimens. 'Per protocol' eradication rates for first, second and thirdline therapy were 74.7% (95% CI: 72.7%-76.4%), 85.3% (95% CI: 81.1%-89.1%) and 89.5% (95% CI: 74.9%-103%) respectively. The overall percentage of patients with H. pylori eradicated after two treatments was 97.8% (95% CI: 97.1%-98.4%), vs 99.9% (95% CI: 99.8%-100%) after three treatments. The study found that eradication therapy was most effective in patients with ulcer disease (P < 0.05, P = 0.028), especially in those with duodenal ulcer. Smoking habits did not significantly affect the eradication rate. CONCLUSION: First-line therapy with amoxicillin and clarithromycin produces an H. pylori eradication rate comparable or superior to other studies and secondline treatment can still be triple therapy with amoxicillin and tinidazole. | Giuliana Sereni Francesco Azzolini Lorenzo Camellini Debora Formisano Francesco Decembrino Veronica Iori Cristiana Tioli Maurizio Cavina Francesco Di Mario Giuliano Bedogni Romano Sassatelli | 2012 | World Journal of Gastroenterology2012,18,33: | 4 |
| 2 | Proposal of a new clinical index predictive of endoscopic severity in ulcerative colitis显示文摘 | Azzolini F Pagnini C Camellini L | 2005 | Dig Dis Sci2005,50,2: | 1 |
| 3 | Evidence for an association of high blood pressure and hgperinsulinemia in obese man显示文摘 | Manicardi V Camellini L Bellodi G | 1986 | J Clin Endocrinol Metab1986,86,: | 1 |
| 4 | Ga -68 DOTATOC PET, endoscopic ultrasonography, and multide- tector CT in the diagnosis of duodenopancreatic neuroendo- crine tumors: a single - centre retrospective study 显示文摘 | VERSARI A CAMELLINI L CARLINFANTE G | 2010 | Clin Nucl Med2010,35,5: | 1 |
| 5 | The natural history of up- per gastrointestinal subepithelial tumors: a muhicenter endoscopic ul- trasound survey显示文摘 | Gill K R Camellini L Conigliaro R | 2009 | J Clin Gastroenteml2009,43,8: | 1 |
| 6 | Variant estrogen receptors mRNA species detected in human primary hepatocellular carcinoma显示文摘 | Villa E Camellini L Dogani A | 1995 | Cancer Res1995,55,: | 1 |
| 7 | Type of estrogen receptor determines response to antiestrogen therapy in hepatocellular carcinoma显示文摘 | Villa E Camellini L Fantoni E | 1996 | Cancer Res1996,56,: | 1 |
| 8 | Variant estrogen receptor messenger RNA species detected in human primary hepatocellular carcinoma显示文摘 | Villa E Camellini L Dugani A Zucchi F Grottola A Merighi A Buttafoco P Losi L Manenti F | 1995 | Cancer Res1995,55,3: | 1 |
| 9 | Variant liver estrogen receptor transcripts already occur at an early stage of chronic liver disease显示文摘 | Villa E Dugani A Moles A Camellini L Grottola A Buttafoco P Merighi A Ferretti I Esposito P Miglioli L Bagni A Troisi R De Hemptinne B Praet M Callea F Manenti F | 1998 | Hepatology1998,27,4: | 1 |
| 10 | Type of estrogen receptor determines response to antiestregen therapy in hepatocellular carcinoma显示文摘 | Villa E Dugani A Fantoni E Camellini L Buttafoco P Grottola A Pompei G De Santis M Ferrari A Manenti F | 1996 | Cancer Res1996,56,17: | 1 |
| 11 | Proposal of a new clinical index predictive of endoscopic severity in ulcerative colitis显示文摘 | Azzolini F Pagnini C Camellini L | 2005 | Dig Dis Sci2005,50,: | 1 |
| 12 | Variant estrogen receptor messenger RNA species detected in human pri- mary hepatocellular carcinoma 显示文摘 | Villa E Camellini L Dugani A | 1995 | Cancer Res1995,55,3: | 1 |
| 13 | Proposal of a new clinical index predictive of endoscopic severity in ulcerative colitis显示文摘 | Azzolini F Pagnini C Camellini L | | 0,,02: | 1 |
| 14 | Variant estrogen receptor messenger RNA species detected in human primary hepatocellular carcinoma显示文摘 | Villa E Camellini L Dugani A | 1995 | Cancer Res1995,55,3: | 1 |
| 15 | Proposal of a new clinical index predictive of endoscopic se- verity in ulcerative colitis显示文摘 | Azzolini F Pagnini C Camellini L etal | 2005 | Dig Dis Sci2005,50,: | 1 |
| 16 | Proposal of a new clinical index predictive of endoscopic severity in ulcerative colitis显示文摘 | Azzolini F Pagnini C Camellini L | 2005 | Dig Dis Sci2005,50,2: | 1 |
| 17 | The Natural History of Upper Gastrointestinal Subepithelial Tumors: A Multicenter Endoscopic Ultrasound Survey显示文摘 | Kanwar R. S. Gill Lorenzo Camellini Rita Conigliaro Romano Sassatelli Francesco Azzolini Alessandro Messerotti Timothy A. Woodward Micheal B. Wallace Laith H. Jamil Massimo Raimondo | 2009 | Journal of Clinical Gastroenterology2009,,8: | 1 |
| 18 | A randomized clinical trial comparing 22G and 25G needles in endoscopic ultrasound-guided fine-needle aspiration of solid lesions显示文摘 | L. Camellini G. Carlinfante F. Azzolini V. Iori M. Cavina G. Sereni F. Decembrino C. Gallo I. Tamagnini R. Valli S. Piana C. Campari G. Gardini R. Sassatelli | 2011 | Endoscopy2011,,08: | 1 |
| 19 | Intrinsic and Extrinsic Exciton Recombination Pathways in AgInS_(2)Colloidal Nanocrystals显示文摘Ternary I-III-VI2 nanocrystals(NCs),such as AgInS_(2) and CuInS_(2),are garnering interest as heavy-metal-free materials for photovoltaics,luminescent solar concentrators,LEDs,and bioimaging.The origin of the emission and absorption properties in this class of NCs is still a subject of debate.Recent theoretical and experimental studies revealed that the characteristic Stokesshifted and long-lived luminescence of stoichiometric CuInS_(2) NCs arises from the detailed structure of the valence band featuring two sublevels with different parity.The same valence band substructure is predicted to occur in AgInS_(2) NCs,yet no experimental confirmation is available to date.Here,we use complementary spectroscopic,spectro-electrochemical,and magneto-optical investigations as a function of temperature to investigate the band structure and the excitonic recombination mechanisms in stoichiometric AgInS_(2) NCs.Transient transmission measurements reveal the signatures of two subbands with opposite parity,and photoluminescence studies at cryogenic temperatures evidence a dark state emission due to enhanced exchange interaction,consistent with the behavior of stoichiometric CuInS_(2) NCs.Lowering the temperature as well as applying reducing electrochemical potentials further suppress electron trapping,which represents the main nonradiative channel for exciton decay,leading to nearly 100%emission efficiency. | Matteo L.Zaffalon Valerio Pinchetti Andrea Camellini Sergey Vikulov Chiara Capitani Bing Bai Meng Xu Francesco Meinardi Jiatao Zhang Liberato Manna Margherita Zavelani-Rossi Scott A.Crooker Sergio Brovelli | 2021 | Energy Material Advances2021,,1: | 0 |